U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07178574) titled 'Polish Version Dyspnea in Amyotrophic Lateral Sclerosis' on Sept. 10.
Brief Summary: Amyotrophic lateral sclerosis is a fatal disease with progressive degeneration of central and peripheral motor neurons. Weakness of pharyngeal and respiratory muscles lead to dyspnea, which is present in up to 80% of patients. Dyspnea in Amyotrophic Lateral Sclerosis (DALS-15) is a questionnaire designed to measure the severity of dyspnea. DALS-15 was originally created in German language. The aim of this study is to validate the Polish-language version of DALS-15.
Study Start Date: Oct. 01
Study Type: OBSERVATIONAL
Condition:
Amyotrophic Later...